Skip to main content

Peer Review reports

From: The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database

Original Submission
22 Nov 2024 Submitted Original manuscript
22 Nov 2024 Author responded Author comments - Zi Huang
31 Dec 2024 Reviewed Reviewer Report
12 Jan 2025 Reviewed Reviewer Report
24 Jan 2025 Author responded Author comments - Zi Huang
Resubmission - Version 2
22 Nov 2024 Submitted Manuscript version 2
26 Jan 2025 Author responded Author comments - Zi Huang
Resubmission - Version 3
26 Jan 2025 Submitted Manuscript version 3
Publishing
27 Jan 2025 Editorially accepted
7 Feb 2025 Article published 10.1186/s40360-025-00861-y

You can find further information about peer review here.

Back to article page